C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 317/44 (2006.01) A61K 31/10 (2006.01) A61K 31/277 (2006.01) A61K 31/397 (2006.01) A61K 31/4164 (2006.01) A61K 31/4196 (2006.01) C07D 205/04 (2006.01) C07D 207/10 (2006.01) C07D 211/38 (2006.01) C07D 213/71 (2006.01) C07D 233/64 (2006.01) C07D 241/08 (2006.01) C07D 249/08 (2006.01) C07D 271/10 (2006.01) C07D 295/096 (2006.01)
Patent
CA 2577837
Compounds of formula (I) are potent and selective antagonists of the human 5- HT2A receptor, and hence useful in treatment of a variety of adverse conditions of the CNS.
La présente invention décrit des composés de formule I : I qui sont des antagonistes puissants et sélectifs du récepteur humain 5-HT2A, et qui peuvent à ce titre être employés dans le traitement de nombreuses maladies du SNC.
Castro Pineiro Jose Luis
Cooper Laura Catherine
Gilligan Myra
Humphries Alexander Charles
Hunt Peter Alan
Merck Sharp & Dohme Limited
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Diarylsulfones as 5-ht2a antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diarylsulfones as 5-ht2a antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diarylsulfones as 5-ht2a antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2031553